| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Tuesday’s Close |
|---|---|---|---|---|---|
| GSK | GlaxoSmithKline PLC | $39.21 | $97.25B | Buy |
Pfizer consumer health deal will help fuel investments in pharma, vaccines, says GSK CEO
https://www.cnbc.com/2018/12/19/gsk-ceo-emma-walmsley-on-pfizer-consumer-health-deal-.html
Dec 19, 2018 - Pfizer and GSK will combine their consumer health units and plan to spin the joint venture off.
7
Wall Street Breakfast: One Rate Hike Over The Line?
https://seekingalpha.com/article/4229148-wall-street-breakfast-one-rate-hike-line?source=feed_tag_wall_st_breakfast
Dec 19, 2018 - Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on iTunes, Stitcher and SoundCloud (click the highlighted links). The Federal Reserve is widely expected to r
0
Glaxo, Pfizer to Merge Consumer Health Units, Form New JV
http://www.zacks.com/stock/news/343705/glaxo-pfizer-to-merge-consumer-health-units-form-new-jv?cid=CS-ZC-FT-343705
Dec 19, 2018 - Glaxo (GSK) and Pfizer agree to merge their consumer healthcare units into a new joint venture (JV) with almost $13 billion in annual sales. Glaxo will eventually spin-off the joint venture.
0
Europe stocks higher after Italy budget breakthrough; Fed meeting in focus; GSK jumps 5%
https://www.cnbc.com/2018/12/19/european-markets-investors-await-federal-reserve-rate-decision.html
Dec 19, 2018 - European stocks were higher Wednesday, after Italy and the European Union reached a breakthrough on Rome's 2019 budget plans.
1
M&A Updates: The Conditions For ANTA Sports/Amer Sports Will Be Challenging
https://seekingalpha.com/article/4228056-m-updates-conditions-anta-sports-amer-sports-will-challenging?source=feed_all_articles
Dec 13, 2018 - ANTA will have to get 90% of Amer shareholders approval.Takeda/Shire deal is done.Hydro One/Avista deal killed by Washington regulators.Aurora Cannabis/ICC Labs deal brought 11% in a bit more than a m
0
What One Sector Offers Safety As Markets Get Roiled?
https://seekingalpha.com/article/4227443-one-sector-offers-safety-markets-get-roiled?source=feed_all_articles
Dec 10, 2018 - Few sectors offer safety when markets are falling.Discounts in stocks creating compelling entry points for investors who are also seeking dividend income.Chip stocks in the technology sector, for inst
0
There Are Better Drug Stocks Than GlaxoSmithKline - Cramer's Lightning Round (12/7/18)
https://seekingalpha.com/article/4227324-better-drug-stocks-glaxosmithkline-cramers-lightning-round-12-7-18?source=feed_tag_cramers_picks
Dec 10, 2018 - Abbott Laboratories is a great buy.Waste Management is the best of breed.Stay away from housing stocks.
0
Cramer's lightning round: There are better drug stocks to own than GlaxoSmithKline
https://www.cnbc.com/2018/12/07/cramers-lightning-round-drug-stock-glaxosmithkline-isnt-delivering.html
Dec 07, 2018 - Jim Cramer flies through his responses to callers' stock questions, including one about the prospects for a drugmaker's stock.
0
Pharma Stock Roundup: Glaxo's TESARO Buyout & Horlicks Sale, ASH Cancer Data Updates
http://www.zacks.com/stock/news/341786/pharma-stock-roundup-glaxos-tesaro-buyout-horlicks-sale-ash-cancer-data-updates?cid=CS-ZC-FT-341786
Dec 07, 2018 - Glaxo (GSK) to buy TESARO and divest Horlicks brand to Unilever. ASH cancer presentations grab headilines.
0
Gilead (GILD) Announces Data on CAR T Therapy Candidate
http://www.zacks.com/stock/news/341121/gilead-gild-announces-data-on-car-t-therapy-candidate?cid=CS-ZC-FT-341121
Dec 04, 2018 - Gilead (GILD) announces data on chimeric antigen receptor T (CAR T) cell therapy candidate at the ASH for the treatment of patients with relapsed or refractory acute lymphoblastic leukemia.
0